These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 12709574

  • 1. Novel inhibitors of neuronal nitric oxide synthase.
    Di Giacomo C, Sorrenti V, Salerno L, Cardile V, Guerrera F, Siracusa MA, Avitabile M, Vanella A.
    Exp Biol Med (Maywood); 2003 May; 228(5):486-90. PubMed ID: 12709574
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of neuronal nitric oxide synthase by N-phenacyl imidazoles.
    Sorrenti V, Di Giacomo C, Salerno L, Siracusa MA, Guerrera F, Vanella A.
    Nitric Oxide; 2001 Feb; 5(1):32-8. PubMed ID: 11178934
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Binding of L-arginine and imidazole suggests heterogeneity of rat brain neuronal nitric oxide synthase.
    Gorren AC, Schmidt K, Mayer B.
    Biochemistry; 2002 Jun 18; 41(24):7819-29. PubMed ID: 12056914
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
    Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK.
    Br J Pharmacol; 1996 Sep 18; 119(2):423-31. PubMed ID: 8886430
    [Abstract] [Full Text] [Related]

  • 8. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
    Chabin RM, McCauley E, Calaycay JR, Kelly TM, MacNaul KL, Wolfe GC, Hutchinson NI, Madhusudanaraju S, Schmidt JA, Kozarich JW, Wong KK.
    Biochemistry; 1996 Jul 23; 35(29):9567-75. PubMed ID: 8755738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.
    Gómez-Vidal JA, Martásek P, Roman LJ, Silverman RB.
    J Med Chem; 2004 Jan 29; 47(3):703-10. PubMed ID: 14736250
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of neuronal nitric oxide synthase by 6-nitrocatecholamines, putative reaction products of nitric oxide with catecholamines under oxidative stress conditions.
    Palumbo A, Astarita G, d'Ischia M.
    Biochem J; 2001 May 15; 356(Pt 1):105-10. PubMed ID: 11336641
    [Abstract] [Full Text] [Related]

  • 16. Novel inhibitors of nitric oxide synthase with antioxidant properties.
    Salerno L, Modica MN, Romeo G, Pittalà V, Siracusa MA, Amato ME, Acquaviva R, Di Giacomo C, Sorrenti V.
    Eur J Med Chem; 2012 Mar 15; 49():118-26. PubMed ID: 22280820
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tetrahydrobiopterin protects against guanabenz-mediated inhibition of neuronal nitric-oxide synthase in vitro and in vivo.
    Dunbar AY, Jenkins GJ, Jianmongkol S, Nakatsuka M, Lowe ER, Lau M, Osawa Y.
    Drug Metab Dispos; 2006 Sep 15; 34(9):1448-56. PubMed ID: 16738031
    [Abstract] [Full Text] [Related]

  • 20. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
    Lefèvre-Groboillot D, Frapart Y, Desbois A, Zimmermann JL, Boucher JL, Gorren AC, Mayer B, Stuehr DJ, Mansuy D.
    Biochemistry; 2003 Apr 08; 42(13):3858-67. PubMed ID: 12667076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.